JThe following companies are expected to report their results before the market opens on 05/04/2022. See our results calendar for a full list of expected results releases.

CVS Health Society (CVS) reports for the quarter ending March 31, 2022. The drugstore company’s consensus earnings-per-share forecast from 8 analysts who track the stock is $2.14. This value represents an increase of 4.90% compared to the same quarter last year. Over the past year, CVS has exceeded expectations every quarter. The highest was in the 4th calendar quarter where they beat consensus by 2.06%. Zacks Investment Research reports that the 2022 price-to-earnings ratio for CVS is 11.73 versus an industry ratio of 5.60, implying that they will have higher earnings growth than their competitors in the same industry.

Regeneron Pharmaceuticals, Inc. (REGN) reports for the quarter ending March 31, 2022. The consensus earnings per share forecast for the biomedical company (gene) from the 6 analysts who track the stock is $9.37. This value represents a decrease of 7.14% compared to the same quarter last year. Over the past year, REGN has exceeded expectations every quarter. The highest was in the 4th calendar quarter where they beat consensus by 28.29%. Zacks Investment Research reports that the 2022 P/E ratio for REGN is 15.23 versus an industry ratio of -12.20, implying that they will have higher earnings growth than their competitors in the same industry.

Marriott International (MAR) reports for the quarter ending March 31, 2022. The hotel company’s consensus earnings-per-share forecast from the 8 analysts who track the stock is $0.94. This value represents an increase of 840.00% compared to the same quarter last year. Over the past year, MAR has exceeded expectations every quarter. The highest was in the 4th calendar quarter where they beat consensus by 27.45%. Zacks Investment Research reports that the 2022 price-to-earnings ratio for MAR is 31.98 versus an industry ratio of -45.40, implying that they will have higher earnings growth than their competitors in the same industry.

Moderna, Inc. (MRNA) reports for the quarter ending March 31, 2022. The consensus earnings forecast for the biomedical company (gene) from 9 analysts who track the stock is $5.18. This value represents an increase of 82.39% compared to the same quarter last year. MRNA missed consensus earnings per share in the 3rd calendar quarter of 2021 by -14.06%. Zacks Investment Research reports that the 2022 price-to-earnings ratio for MRNA is 5.27 versus an industry ratio of -12.20, implying that they will have higher earnings growth than their competitors in the same industry.

Emerson Electric Company (EMR) reports for the quarter ending March 31, 2022. The machinery company’s consensus earnings-per-share forecast from the 6 analysts who track the stock is $1.18. This value represents an increase of 21.65% compared to the same quarter last year. Over the past year, EMR has exceeded expectations every quarter. The highest was in the 4th calendar quarter where they beat consensus by 6.06%. Zacks Investment Research reports that the 2022 price-to-earnings ratio for EMR is 18.16 versus an industry ratio of 11.60, implying that they will have higher earnings growth than their competitors in the same industry.

Johnson Controls International plc (JCI) reports for the quarter ending March 31, 2022. The security and protection company’s consensus earnings per share forecast from 7 analysts who track the stock is $0.63. This value represents an increase of 21.15% compared to the same quarter last year. In the past year, JCI met analysts’ expectations once and exceeded them the other three quarters. Zacks Investment Research reports that the 2022 P/E ratio for JCI is 18.82 versus an industry ratio of -8.20, implying that they will have higher earnings growth than their competitors in the same industry.

Barrick Gold Corporation (GOLD) reports for the quarter ending March 31, 2022. The consensus earnings forecast for the gold mining company from 8 analysts who track the stock is $0.23. This value represents a decrease of 20.69% compared to the same quarter last year. Over the past year, GOLD has exceeded expectations every quarter. The highest was in the 4th calendar quarter where they beat consensus by 16.67%. Zacks Investment Research reports that the 2022 P/E ratio for GOLD is 18.78 vs an industry ratio of -4.40, implying they will have higher earnings growth than their competitors in the same industry .

Ferrari S.A. (RACE) reports for the quarter ending March 31, 2022. The consensus earnings forecast for the auto (truck) company from 3 analysts who track the stock is $1.26. This value represents a decrease of 5.97% compared to the same quarter last year. Over the past year, RACE has exceeded expectations every quarter. The highest was in the 4th calendar quarter where they beat consensus by 30.39%. Zacks Investment Research reports that the 2022 price-to-earnings ratio for RACE is 40.96 versus an industry ratio of 5.40, implying that they will have higher earnings growth than their competitors in the same industry.

IDEXX Laboratories, Inc. (IDXX) reports for the quarter ending March 31, 2022. The medical devices company’s consensus earnings-per-share forecast from the 6 analysts who track the stock is $2.25. This value represents a decrease of 4.26% compared to the same quarter last year. Over the past year, IDXX has exceeded expectations every quarter. The highest was in the 4th calendar quarter where they beat consensus by 13.17%. Zacks Investment Research reports that the 2022 price-to-earnings ratio for IDXX is 45.76 versus an industry ratio of -23.30, implying that they will have higher earnings growth than their competitors in the same industry.

Cheniere Energy, Inc. (LNG) reports for the quarter ending March 31, 2022. The consensus earnings per share forecast from the 6 analysts who track the stock is $3.34. LNG reported earnings of $1.54 per share for the same quarter a year ago; representing an increase of 116.88%.Yum! Marks, Inc. (YUM) reports for the quarter ending March 31, 2022. The restaurant company’s consensus earnings-per-share forecast from the 9 analysts who track the stock is $1.07. This value represents a no change for the same quarter last year. YUM missed consensus earnings per share in the 4th calendar quarter of 2021 by -5.56%. Zacks Investment Research reports that the 2022 price-to-earnings ratio for YUM is 24.22 versus an industry ratio of 11.90, implying that they will have higher earnings growth than their competitors in the same industry.

Trane Technologies plc (TT) reports for the quarter ending March 31, 2022. The technology services company’s consensus earnings per share forecast from 7 analysts who track the stock is $1.00. This value represents a decrease of 0.99% compared to the same quarter last year. TT missed consensus earnings per share in the 3rd calendar quarter of 2021 by -3.23%. Zacks Investment Research reports that the 2022 price-to-earnings ratio for TT is 19.96 versus an industry ratio of -2.50, implying that they will have higher earnings growth than their competitors in the same industry.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.